Jane Street Group, LLC Genmab A/S Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.13 - $30.27 $361,067 - $434,919	14,368 New	14,368 $361,000
Q3 2023 Nov 14, 2023	SELL	$35.27 - $42.24 $6.08 Million - $7.28 Million	-172,462 Reduced 90.24%	18,651 $657,000
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $509,874 - $585,401	-13,633 Reduced 6.66%	191,113 $7.26 Million
Q1 2023 May 15, 2023	BUY	$34.88 - $43.22 $6.65 Million - $8.24 Million	190,759 Added 1363.83%	204,746 $7.73 Million
Q4 2022 Feb 14, 2023	SELL	$33.8 - $47.06 $156,054 - $217,276	-4,617 Reduced 24.82%	13,987 $592,000
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $586,398 - $6.95 Million	18,604 New	18,604 $604,000
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $586,398 - $6.95 Million	18,604 New	18,604 $604,000
Q1 2022 May 17, 2022	SELL	$30.95 - $39.68 $2.37 Million - $3.03 Million	-76,424 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$35.87 - $47.12 $688,058 - $903,855	-19,182 Reduced 20.06%	76,424 $3.08 Million
Q3 2021 Nov 16, 2021	BUY	$41.55 - $48.72 $3.97 Million - $4.66 Million	95,606 New	95,606 $4.18 Million
Q2 2021 Aug 16, 2021	SELL	$32.88 - $44.57 $1.83 Million - $2.48 Million	-55,672 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$30.92 - $44.4 $1.72 Million - $2.47 Million	55,672 New	55,672 $1.83 Million
Q4 2020 Feb 17, 2021	SELL	$33.66 - $40.76 $216,366 - $262,005	-6,428 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$33.07 - $38.68 $212,573 - $248,635	6,428 New	6,428 $233,000
Q4 2019 Feb 14, 2020	SELL	$18.88 - $24.14 $3.45 Million - $4.42 Million	-182,955 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $3.29 Million - $3.91 Million	182,955 New	182,955 $3.71 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account